Psychedelic Drug Industry Analysis: Forecast Market Size, Major Players And Their Strategies, And Key Segments - By The Business Research Company

News provided by

May 04, 2023, 05:30 ET

The Business Research Company's Global Market Reports Are Now Updated With The Latest Market Sizing Information For The Year 2023 And Forecasted To 2032

LONDON, May 4, 2023 /PRNewswire/ -- As per The Business Research Company's Psychedelic Drugs Global Market Report 2023, the rise in mental illness cases is likely to drive the psychedelic drugs market ahead in the forecast period. Psychedelic drugs are used to effectively treat depression and post-traumatic stress disorder.

During the forecast period the global psychedelic drugs market is expected to expand at a consistent rate. The global psychedelic drugs market size is expected to grow from $4.2 billion in 2022 to $4.8 billion in 2023 at a compound annual growth rate (CAGR) of more than 14%. The psychedelic drugs market size is then expected to grow to $8.3 billion in 2027 at a CAGR of more than 14%.

North America was the largest region in the psychedelic drug market in 2022, with the USA being among the countries with promising growth potential. According to the National Alliance on Mental Illness (NAMI), a mental health organization based in the United States, 21% of adults in America, or 52.9 million people, were suffering from mental illness in 2020.

Learn More On The Psychedelic Drugs Market Report – https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Major psychedelic drugs companies in the market include Johnson & Johnson, Pfizer, Hikma Pharmaceuticals PLC, Roche Holding AG, Merck & Co Inc., Jazz Pharmaceuticals plc, COMPASS Pathways PLC, Celon Pharma S.A., Numinus Wellness Inc., AbbVie, Mylan N.V., Avadel, NeuroRx Inc., Klarisana, AstraZeneca, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Allergan Inc., Mota Ventures Corp., Seelos Therapeutics, Emmes Company, and Novatris International AG.

To stay relevant in the market, psychedelic drugs manufacturers are introducing new products and treatments. For instance, Hikma Pharmaceuticals Ltd., a UK-based pharmaceutical company, launch ed KLOXXADO in August 2021. KLOXXADO is an 8-mg naloxone HCl nasal spray. This spray is used to treat adults and children who experience respiratory depression and/or central nervous system depression as a result of an opiate overdose.

Request A Free Sample Of The Psychedelic Drugs Market Report – https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

The global psychedelic drugs market is segmented

By type into: lysergic acid diethylamid (LSD), ketamine, phencyclidine, gamma hydroxybutyric acid (GHB), salvia
By disease indication into: depression, PTSD;
By origin: natural, synthetic; by application into treatment-resistant depression, opiate addiction, post- traumatic stress disorder, narcolepsy, panic disorders
By distribution channel: hospitals pharmacy, retail pharmacy, online pharmacy

The Business Research Company's psychedelic drugs market report describes and explains the market from 2017 to 2022, referred to as the historic period, and 2022 to 2027, referred to as the forecast period, with additional forecasts from 2027 to 2032. The study assesses psychedelic drug industry statistics such as market size, regional market shares, competitors, segments, trends, and opportunities.

View More Similar Market Reports:

Brain Health Supplements Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/brain-health-supplements-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

Mental Health Apps Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Interested to know more about The Business Research Company?

The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

The World's Most Comprehensive Database

The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users make better strategic decisions.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model